8:00-17:00	Registration [Hotel Lobby]
8:30-12:00	Trip to the Gateway Arch National Park (optional, see the Information page)
13:00	SHVM Board Meeting (for board members only)
14:00-16:00	Trainee Workshop
14:00-14:30	Craig Lygate (Glasgow, United Kingdom) Cutting edge tools for the evaluation of myocardial metabolism and function
14:30-16:00	Demonstration of small animal model imaging Jie Zheng, James Quirk, Yongjian Liu, Cornelius von Morze (Saint Louis, MO, USA) Small animal ultrasound and surgical techniques Attila Kovacs, Carla J. Weinheimer (Saint Louis, MO, USA)
16:30-17:00	Break time
Opening Session
17:00-17:15	Welcome from Organisers and SHVM President
17:15-18:00	Special Lecture – Lung-Heart Crosstalk Chairs: Linda R. Peterson (Saint Louis, MO, USA) and Zoltan P. Arany (Philadelphia, PA, USA) Andrew J. Murray (Cambridge, United Kingdom) Hypoxia and cardiac metabolism: what Sherpas can teach us!
18:00-22:00	Informal dinner reception [Poolside at Hotel]

8:00-17:00	Registration [Hotel Lobby]
6:30-7:30	Optional Run/Walk (~1-3 mi / ~1.6-5 km) – Shaw Park (near hotel) Leaders: Lauren K. Park (St. Louis, MO, USA) and Adam R. Wende (Birmingham, AL, USA)
7:00-8:00	Breakfast
Session 1 • Cardiovascular - Pancreas & Diabetes Connections Chairs: Camila Manrique-Acevedo (Columbia, MO, USA) and Gary D. Lopaschuk (Edmonton, Canada)
8:00-9:00	Keynote Lecture Robert E. Gerszten (Boston, MA, USA) Mining the blood for new cardiometabolic hormones
9:00-9:30	Yang Kevin Xiang (Davis, CA, USA) Impacts of pancreatic and gut hormones on cardiac metabolism in HFpEF
9:30-10:00	Kim Mellor (Auckland, New Zealand) Cardiac fructose metabolism in diabetes
10:00-10:30	Coffee break
10:30-11:00	John R. Ussher (Edmonton, Canada) Ketones, insulin resistance and GLP-1
11:00-11:15	Short talk: Justin Berger (Philadelphia, PA, USA) Whole body MondoA deletion protects against diet-induced obesity
11:15-11:30	Short talk: Sean Tatum (St. Louis, MO, USA) Cardiomyocyte derived ceramides drive diastolic heart failure
11:30-12:15	Early Career Investigator ‘speed-mentoring’
12:15-13:00	Special Lecture & Lunch Anne Carol Goldberg (St. Louis, MO, USA) Lipid management with cholesterol-lowering medications
Session 2 • Cardiovascular – Liver Connections Chairs: Renata O. Pereira (Iowa City, IA, USA) and Bellina Mushala (Pittsburgh, PA, USA)
13:00-13:30	Jiandie Lin (Ann Arbor, MI, USA) Interorgan crosstalk and tissue microenvironment in metabolic liver disease
13:30-13:45	Short talk: Mandy Chan (St. Louis, MO, USA) Induction of TFEB promotes Kupffer cell survival and reduces liver pathology in metabolic dysfunction-associated steatotic liver disease (MASLD)
13:45-14:15	Konstantinos Drosatos (Cincinnati, OH, USA) Hepatocardiac signaling in charge of cardiac hypertrophy
14:15-14:45	Joel D. Schilling (St. Louis, MO, USA) The cardio-hepatic axis in right heart failure
14:45-15:00	Short talk: Nikole Byrne (Graz, Austria) Loss of SIRT5 accelerates the development of pressure-overload induced heart failure
Session 3 • The “William C. Stanley” Early Investigator Awards Chairs: Daniel P. Kelly (Philadelphia, PA, USA) and Rebecca Ritchie (Melbourne, Australia)
15:00-15:15	Kylene Harold (Oklahoma City, OK, USA) Impacts of PFKFB2-mediated glycolytic regulation on cardiac function and electrophysiology
15:15-15:30	Sumeet Khetarpal (Boston, MA, USA) Cardiac adaptation to endurance exercise training requires suppression of GDF15 via PGC-1α
15:30-15:45	Marcos Castro Guarda (Oxford, United Kingdom) Exploring the dual role of fumarate as an intracellular and extracellular hypoxia-induced signaling molecule
15:45-16:00	Stephanie Kereliuk (Durham, NC, USA) GRK2-mediated cardiomyocyte signaling factors are responsible for heart-fat communication
16:00-17:45	Poster Session I / Exhibitions
17:45-18:15	Travel time
18:15-22:00	Formal Dinner – St. Louis Art Museum

8:00-17:00	Registration [Hotel Lobby]
7:00-8:00	Breakfast
Session 4 • Cardiovascular – Cancer Connections Chairs: Heinrich Taegtmeyer (Houston, TX, USA) and Luc Bertrand (Brussels, Belgium)
8:00-8:30	Tomas Neilan (Boston, MA, USA) Prevention of Adriamycin-induced cardiotoxicity by SLGT2 inhibitors
8:30-9:00	Jason Dyck (Edmonton, Canada) Cardio-oncology: cancer therapy and cardiovascular injury
9:00-9:30	Vlad G. Zaha (Dallas, TX, USA) Metabolic imaging of cardiotoxic anticancer chemotherapy
9:30-9:45	Short talk: Gregory Ducker (Salt Lake City, UT, USA) Direct mitochondrial oxidation of circulating lactate by cardiac tissue is protective in models of heart failure
9:45-10:00	Short talk: Matthieu Zolondek (Edmonton, Canada) Cardiac-specific ROMO1 overexpression prevents loss of mitochondrial structure and function in a murine model of heart failure
10:00-12:00	Poster Session II / Exhibitions
12:00-13:00	Special Lecture & Lunch Mark Huffman (St. Louis, MO, USA) Food is medicine: the great implementation gap
Session 5 • Cardiovascular – Adipose Connections Chairs: Sharon Cresci (St. Louis, MO, USA) and Ira J. Goldberg (New York, NY, USA)
13:00-13:30	Christopher T. Nguyen (Cleveland, OH, USA) CEST-MRI assessment of cardiac energetics following weight loss
13:30-14:00	Ippei Shimizu (Osaka, Japan) Senolysis and the suppression of pro-fibrotic BATokine become therapies for cardiovascular-metabolic diseases
14:00-14:30	Saumya Das (Boston, MA, USA) Adipose-derived regulators of inter-organ communication in cardiometabolic disease
14:30-15:00	Coffee break
15:00-15:30	Kristin Stanford (Columbus, OH, USA) 12,13-di-HOME: a mediator of cardiac function
15:30-16:00	Clair Crewe (St. Louis, MO, USA) Adipose tissue to heart crosstalk by traveling mitochondria
16:00-16:15	Short talk: Kae Won Cho (Cheonan, Republic of Korea) Obesity-induced imprinting of hematopoietic stem cells exacerbates atherosclerosis progression
16:15-16:30	Short talk: Lauren Watson (Auckland, New Zealand) A common interleukin-6 promoter variant (-174 G/C) protects against cardiac hypertrophy in female but not male mice fed a high fat diet
16:30-17:30	Break time
17:30-18:00	Travel time
18:00-22:00	Gala Dinner – Grant’s Farm

7:00-8:00	Breakfast
8:00-9:00	"William C. Stanley" Award Lecture Chairs: Lisa C. Heather (Oxford, United Kingdom) and Adam R. Wende (Birmingham, AL, USA) Martin E. Young (Birmingham, AL, USA) Circadian regulation of cardiac metabolism & beyond – good times interacting with friends
Session 6 • Cardiovascular – Brain Connections Chairs: Lisa C. Heather (Oxford, United Kingdom) and Adam R. Wende (Birmingham, AL, USA)
9:00-9:30	Florin Despa (Lexington, KY, USA) Amylin pathology underlying microvascular and metabolic deficits
9:30-10:00	Min-Seon Kim (Seoul, Republic of Korea) Hypothalamic mitochondrial stress response mediates the beneficial metabolic effects of exercise
10:00-10:30	Olujimi Ajijola (Los Angeles, CA, USA) Heart-brain connections to mitochondria/arrhythmia
10:30-11:00	Coffee break
Session 7 • Cardiovascular – GI/Immune Connections Chairs: Kory J. Lavine (St. Louis, MO, USA) and Hyoung Kyu Kim (Busan, Republic of Korea)
11:00-11:30	Thomas A. Vallim (Los Angeles, CA, USA) Bile acids and cardiometabolic disease
11:30-12:00	Special Lecture Wilson Tang (Cleveland, OH, USA) The microbiome and the heart
12:00-12:30	Laurel Lee (Boston, MA, USA) T-cell mediated perturbation of endothelial metabolism in CVD
12:30-12:45	Invitation to SHVM 2025 Bordeaux, France • Veronique Lacombe (Stillwater, OK, USA)
12:45-13:00	Concluding Remarks Organizers and SHVM President
13:00-14:00	Box Lunch and/or Depart
Session 8 • SPECIAL SESSION The Korean Society of Lipid and Atherosclerosis (KSoLA) and SHVM Chairs: Jaetaek Kim (KSoLA, Republic of Korea) and Adam R. Wende (SHVM, USA)
14:00-14:20	Nada A. Abumrad (St. Louis, MO, USA) CD36 variants on risk of vascular and metabolic disease
14:20-14:40	Soon Jun Hong (Seoul, Republic of Korea) Statin-associated muscle symptoms (SAMS) in Korea
14:40-15:00	Hyun Kang (Seoul, Republic of Korea) COVID-19 vaccination-related myocarditis, pericarditis and myopericarditis: an umbrella review of systematic reviews and updated meta-analyses
15:00-15:30	Coffee break
15:30-15:50	Sung Wan Chun (Asan, Republic of Korea) Antioxidative profiles of SGLT2 inhibitors in heart and kidney
15:50-16:10	Samuel Klein (St. Louis, MO, USA) Why does excess adiposity impair cardiometabolic health?
16:10-16:30	Arpita Vyas (St. Louis, MO, USA) Gestational hyperandrogenism: cardiometabolic programming
16:30-17:00	Discussion and See You Next Year in Bordeaux!

When preparing your poster, please remember that the available area on each poster board is 4 x 6 feet (1.2 x 1.8 m), height x width. Note that the orientation is landscape, not portrait. Prepare your poster accordingly, to whatever size you prefer, ensuring that it remains within the confines of the poster board.

Correct format...    Wrong format...

Poster presenters are required to be available for discussion during their assigned session. The distribution of posters in the two sessions is indicated below.

• 9 September
• 10 September

• Poster Session I • Monday 9 September • 16:00-17:45

  P1.1 · Victoria Alvarado (Stony Brook, NY, U.S.A.)
  Neutral sphingomyelinase-2 is required for doxorubicin-induced cardiotoxicity

  P1.2 · Justin H. Berger (Philadelphia, PA, U.S.A.)
  Whole body MondoA deletion protects against diet-induced obesity

  P1.3 · Nikole J. Byrne (Graz, Austria)
  Loss of SIRT5 accelerates the development of pressure-overload induced heart failure

  P1.4 · Jordan S.F. Chan (Edmonton, Canada)
  Growth differentiation factor 15 alleviates diastolic dysfunction in mice with experimental diabetic cardiomyopathy

  P1.5 · Mandy M. Chan (St. Louis, MO, U.S.A.)
  Induction of TFEB promotes Kupffer cell survival and reduces liver pathology in metabolic dysfunction-associated steatotic liver disease (MASLD)

  P1.6 · John C. Chatham (Birmingham, AL, U.S.A.)
  Comparing the effects of glucose deprivation and 2-deoxyglucose on O-linked N-acetylglucosamine (O-GlcNAc) protein modification levels in cardiomyocytes

  P1.7 · Ick-Mo Chung (Seoul, Republic of Korea)
  Immobilization and electric shock inhibits arterial endothelial NO formation by CRH through activation of NLRP3 inflammasome and ER stress pathway

  P1.8 · Rachel M. Crawford (Iowa City, IA, U.S.A.)
  Norepinephrine stimulates uncoupled glutamate-supported respiration in cardiac mitochondria mediated by glutamic-oxaloacetic transaminase

  P1.9 · Gregory S. Ducker (Salt Lake City, UT, U.S.A.)
  Direct mitochondrial oxidation of circulating lactate by cardiac tissue is protective in models of heart failure

  P1.10 · Zachary Foulks (St. Louis, MO, U.S.A.)
  Unraveling the mechanism behind the ketogenic diet-mediated reversal of heart failure in mice

  P1.11 · Krzysztof F. Galla (Warszawa, Poland)
  Effects of progesterone and mifepristone on LDL-C  and other lipids serum levels in female rats

  P1.12 · Stefan Gross (Greifswald, Germany)
  Greater visceral fat attenuates inflammation-reducing effects of higher cardiorespiratory fitness: Results from the population-based Study of Health in Pomerania (SHIP-START-2 / SHIP-TREND-0), Germany

  P1.13 · Jin Han (Busan, Republic of Korea)
  Cereblon-induced endoplasmic reticulum stress in diabetic cardiomyopathy

  P1.14 · Gyu Seong Heo (St. Louis, MO, U.S.A.)
  PET imaging of macrophage subset dynamics in atherosclerosis

  P1.15 · Sam M. Hogue (St. Louis, MO, U.S.A.)
  The effects of age and temperature acclimation on ROS production and mitochondrial respiration in western painted turtles (Chrysemys picta bellii)

  P1.16 · Jijun Huang (Los Angeles, CA, U.S.A.)
  Deciphering transcriptome and cell-cell communication signature in heart failure with preserved ejection fraction at single cell resolution

  P1.17 · Amanda D. Ifft (Cleveland, OH, U.S.A.)
  Obesity-driven cardiometabolic regulation: effects on systemic metabolism and interorgan crosstalk in males

  P1.18 · Sumeet Khetarpal (Boston, MA, U.S.A.)
  Cardiac adaptation to endurance exercise training requires suppression of GDF15 via PGC-1α

  P1.19 · Joanna Konieczny (Tromsø, Norway)
  Investigating liver-heart crosstalk during fructose-induced liver steatosis

  P1.20 · Tessa M. Lochetto (St. Louis, MO, U.S.A.)
  PPTC7 maintains cardiac homeostasis by suppressing excessive mitophagy

  P1.21 · Max Merilovich (Halifax, Canada)
  Secretion associated ras-related GTPase-1B (Sar1b): A novel regulator of muscle branched-chain ketoacid content, insulin signaling, and mitochondrial function 

  P1.22 · Bellina Mushala (Pittsburgh, PA, U.S.A.)
  Fatty acid dysregulation drives cardio-hepatic crosstalk in heart failure with preserved ejection fraction (HFpEF)

  P1.23 · Akiyuki Nishimura (Okazaki, Aichi, Japan)
  Supersulfide has critical roles in mitochondrial quality and ischemic resistance of the heart

  P1.24 · Melanie Paillard (Bron, France)
  Human and mouse demonstration of the sarcoplasmic reticulum-mitochondria Ca²⁺ coupling as a new therapeutic target in diabetic cardiomyopathy

  P1.25 · Terri Pietka (St. Louis, MO, U.S.A.)
  Lipoprotein Lipase transport occurs by small extracellular vesicles and is regulated by membrane neutral sphingomyelinase-2

  P1.26 · Kerstin Preuss (Birmingham, AL, U.S.A.)
  The influence of pyruvate dehydrogenase activation on acetylation and its impact on adaption to exercise-induced cardiac hypertrophy

  P1.27 · Zana M. Ross (Pittsburgh, PA, U.S.A.)
  CREBRF regulates cardiomyocyte function and stress response

  P1.28 · Simon Sedej (Graz, Austria)
  Therapeutic potential of atglistatin in heart failure with preserved ejection fraction

  P1.29 · Ayushi Sood (Iowa City, IA, U.S.A.)
  Brown adipose tissue-derived GDF15 promotes survival during myocardial infarction

  P1.30 · Seyed Amirhossein Tabatabaei Dakhili (Edmonton, Canada)
  Chemical development of a new class of succinyl CoA:3-ketoacid CoA transferase (SCOT) inhibitors with reduced brain permeability that promote glucose-lowering in obesity

  P1.31 · Sean M. Tatum (St. Louis, MO, U.S.A.)
  Cardiomyocyte derived ceramides drive diastolic heart failure

  P1.32 · Kensuke Tsushima (Los Angeles, CA, U.S.A.)
  Spatiotemporal phosphoinositide-AKT signaling regulates myocardial T-tubules and membrane dynamics

  P1.33 · Rachel Weiss (St. Louis, MO, U.S.A.)
  Loss of mitochondrial pyruvate transport initiates cardiac glycogen accumulation and heart failure

  P1.34 · Seon Bu Yang (Seoul, Republic of Korea)
  Ubxn4 deficiency aggravates hepatic steatosis in high-fat diet-fed mice

  P1.35 · Jianhua Zhang (Birmingham, AL, U.S.A.)
  Regulation of mitophagy in the heart and brain

  P1.36 · Yuan Zhang (Los Angeles, CA, U.S.A.)
  Increased catabolism of 2-hydroxyglutarate mitigates cardiac remodeling

  P1.37 · Tanin Shafaati (Edmonton, Canada)
  Increasing circulating ketones has minimal impact on the cardiac abnormalities present in a mouse model of Barth syndrome

• Poster Session II • Tuesday, 10 September • 10:00-12:00

  P2.1 · James R. Bell (Bundoora, Australia)
  Proteomic comparison of ovine epicardial and paracardial adipose tissue secretomes suggests paracardial adipose capacity to modulate atrial structure and function

  P2.2 · Hugues Boel (Montreal, Canada)
  Metabolic transcriptional and lipidomic benefits of EZH2 inhibition in the heart: which place for macrophages?

  P2.3 · Marcos Castro Guarda (Oxford, United Kingdom)
  Exploring the dual role of fumarate as an intracellular and extracellular hypoxia-induced signaling molecule

  P2.4 · Jordan S.F. Chan (Edmonton, Canada)
  High fructose-mediated prediabetes does not induce left ventricular diastolic dysfunction in male mice

  P2.5 · Samuel F. Chang (Birmingham, AL, U.S.A.)
  Previously increased cardiac protein O-GlcNAcylation enhances susceptibility to cardiac dysfunction in a response to pressure-overload through immune-cardiac crosstalk

  P2.6 · Emeli Chatterjee (Boston, MA, U.S.A.)
  Big things come in small packages: liver extracellular vesicles targeting the heart during MASLD

  P2.7 · Christopher J. Clarke (Stony Brook, NY, U.S.A.)
  Plasma and serum sphingolipids as biomarkers of doxorubicin-induced cardiotoxicity

  P2.8 · Kaitlyn M.J.H. Dennis (Oxford, United Kingdom)
  Sarcolemmal CD36 content is decreased in human heart failure patients, and is correlated with left ventricular ejection fraction

  P2.9 · Anna A. Faakye (Oklahoma City, OK, U.S.A.)
  The potential role of aspirin in modulating cardiac metabolism in a SIRT3 dependent manner

  P2.10 · Christina Fu (St. Louis, MO, U.S.A.)
  Untangling the cellular and molecular mechanisms of cardiogenic liver disease

  P2.11 · Keshav Gopal (Edmonton, Canada)
  Ovarian hormones mask cardiac dysfunction in an experimental model of type 2 diabetes

  P2.12 · Chea-Myeong J. Ha (Birmingham, AL, U.S.A.)
  Evaluating the impact of pyruvate dehydrogenase kinase (PDK) isozymes on diabetic cardiomyopathy in a type 2 diabetes mouse model

  P2.13 · Kylene M. Harold (Oklahoma City, OK, U.S.A.)
  Impacts of PFKFB2-mediated glycolytic regulation on cardiac function and electrophysiology

  P2.14 · Estelle Heyne (Jena, Germany)
  Hyperbaric oxygen treatment reveals spatiotemporal OXPHOS plasticity in the porcine heart

  P2.15 · Lorenz M.W. Holzner (Cambridge, United Kingdom)
  Hepatocyte-specific HIF2α deletion is associated with myocardial accumulation of lipotoxic lipids, and systolic and diastolic dysfunction in MASLD

  P2.16 · Amanda D. Ifft (Cleveland, OH, U.S.A.)
  Exposing female-specific cardiac mediated crosstalk with brown adipose tissue in metabolic syndrome

  P2.17 · Stephanie Kereliuk (Durham, NC, U.S.A.)
  GRK2-mediated cardiomyocyte signaling factors are responsible for heart-fat communication

  P2.18 · Hyoung Kyu Kim (Busan, Republic of Korea)
  Evogliptin, a DPP-4 inhibitor, prevents cardiac lipotoxicity and mitochondrial dysfunctions in type 2 diabetic mice model

  P2.19 · Véronique A. Lacombe (Stillwater, OK, U.S.A.)
  SARS-COV-2 Infection induces alterations of glucose metabolism in the cardiorespiratory system: Insights on virus-host crosstalk in a feline model

  P2.20 · Thiago N. Menezes (St. Louis, MO, U.S.A.)
  Liver PPTC7 knockout induces mitochondrial dysfunction in mice

  P2.21 · Abigail Mulligan (Baltimore, MD, U.S.A.)
  Metabolism of exogenous acyl-carnitines by cardiomyocytes

  P2.22 · Fawaz T. Naeem (Philadelphia, PA, U.S.A.)
  Targeted quantitative plasma metabolomics identifies metabolite signatures that distinguish heart failure with reduced and preserved ejection fraction

  P2.23 · Jaume R. Otaegui Rabanal (St. Louis, MO, U.S.A.)
  Molecular imaging of immune checkpoint inhibitors aggregated inflammatory response in atherosclerosis

  P2.24 · Mark E. Pepin (Menlo Park, CA, U.S.A.)
  Disrupting NNT prevents cardiometabolic heart failure with preserved ejection

  P2.25 · Noemi Polgar (Honolulu, HI, U.S.A.)
  The exocyst trafficking complex mediates fuel transporter membrane delivery and subsequent fuel uptake in cardiomyocytes

  P2.26 · Julie H. Rennison (Cleveland, OH, U.S.A.)
  Decreased expression of proteins that modulate mitochondrial structure precedes onset of atrial fibrillation in a mouse model of spontaneous atrial fibrillation

  P2.27 · Mya A. Schmidt (Sturgeon County, Canada)
  Sex differences in the murine response to lipopolysaccharides: are endogenous ketones responsible?

  P2.28 · Georgios Siokatas (Cincinnati, OH, U.S.A.)
  Cardiomyocyte KLF5 suppresses the abundance of the entire miR-30 cardioprotective family in ischemic cardiomyopathy through the circular-RNA circPRDM5

  P2.29 · Nikola Srnic (Oxford, United Kingdom)
  A high fat diet enriched with saturated compared to polyunsaturated fat has a more detrimental effect on the hepato-cardiac axis in healthy humans

  P2.30 · Warren Tai (Los Angeles, CA, U.S.A.)
  Cardiac-specific deletion of mitochondrial citrate carrier SLC25A1 does not impair cardiac function under normal or hemodynamic stress conditions

  P2.31 · Benjamin D. Thackray (Cambridge, United Kingdom)
  Maternal obesity alters cardiac mitochondria and substrate metabolism in young adult mouse offspring

  P2.32 · Joseph R. Visker (Salt Lake City, UT, U.S.A.)
  Enhancing mitochondrial pyruvate metabolism ameliorates myocardial ischemic reperfusion injury

  P2.33 · Seon Bu Yang (Seoul, Republic of Korea)
  RUNX3 negatively regulates agonists induced cardiac fibroblasts differentiation

  P2.34 · Joo Mi Yi (Busan, Republic of Korea)
  Epigenetic indicators of cardiovascular disease risk from low-dose ionizing radiation

  P2.35 · Quanjiang Zhang (Los Angeles, CA, U.S.A.)
  NNMT induction causes heart failure attributable to inducible ULK1 loss in cardiomyocytes

  P2.36 · Matthieu C.P. Zolondek (Edmonton, Canada)
  Cardiac-specific ROMO1 overexpression prevents loss of mitochondrial structure and function in a murine model of heart failure